Xiwei Wu Selected Research

Immunosorbents

10/2019	Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes.
5/2011	Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiwei Wu Research Topics

Disease

71	Neoplasms (Cancer) 02/2024 - 01/2005
21	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2006
9	Lung Neoplasms (Lung Cancer) 08/2023 - 01/2008
7	Leukemia 02/2024 - 01/2020
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 01/2020
6	Carcinogenesis 01/2022 - 01/2009
6	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2012
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2017 - 09/2010
5	Prostatic Neoplasms (Prostate Cancer) 02/2017 - 01/2005
4	Disease Progression 01/2024 - 05/2007
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2023 - 10/2021
4	Glioblastoma (Glioblastoma Multiforme) 03/2019 - 01/2012
3	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2022
3	Lymphoma (Lymphomas) 11/2023 - 10/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 04/2011
3	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022 - 01/2021
3	Communicable Diseases (Infectious Diseases) 11/2020 - 07/2020
3	Vaccinia 11/2020 - 07/2020
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 02/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 06/2014
2	Endometrial Neoplasms (Endometrial Cancer) 12/2023 - 11/2023
2	Ovarian Epithelial Carcinoma 12/2023 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2023 - 04/2012
2	Melanoma (Melanoma, Malignant) 03/2023 - 12/2015
2	Hypoxia (Hypoxemia) 02/2023 - 12/2017
2	Inflammation (Inflammations) 02/2023 - 01/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 06/2021
2	Mycosis Fungoides 01/2022 - 11/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2017
2	Diabetes Complications 01/2021 - 12/2014
2	Dysbiosis 01/2021 - 12/2015
2	Rheumatoid Arthritis 01/2020 - 09/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2019 - 01/2018
2	Carcinoma (Carcinomatosis) 04/2018 - 12/2011
2	Colonic Neoplasms (Colon Cancer) 12/2017 - 04/2013
2	Adenocarcinoma 01/2016 - 04/2012
2	Chronic Renal Insufficiency 01/2012 - 05/2011

Drug/Important Bio-Agent (IBA)

21	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2010
15	RNA (Ribonucleic Acid)IBA 01/2024 - 09/2010
13	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2008
13	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2008
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2005
5	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2011
5	Estrogens (Estrogen)FDA Link 02/2023 - 06/2018
5	Hormones (Hormone)IBA 12/2021 - 12/2006
4	Phosphotransferases (Kinase)IBA 10/2021 - 08/2015
4	AntigensIBA 01/2021 - 01/2005
4	Histones (Histone)IBA 01/2017 - 05/2007
3	venetoclaxIBA 04/2024 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 04/2013
3	Phenobarbital (Luminal)FDA Link 01/2024 - 01/2019
3	IntegrinsIBA 08/2023 - 09/2020
3	Estrogen ReceptorsIBA 02/2023 - 06/2018
3	Messenger RNA (mRNA)IBA 01/2023 - 04/2013
3	Insulin (Novolin)FDA Link 01/2023 - 12/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2015
3	CytokinesIBA 06/2021 - 06/2012
3	VaccinesIBA 11/2020 - 07/2020
3	EnzymesIBA 10/2019 - 05/2011
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2009
3	ChromatinIBA 05/2012 - 05/2007
3	Aromatase InhibitorsIBA 06/2008 - 12/2006
2	Arginine (L-Arginine)FDA Link 02/2024 - 01/2021
2	Small Cytoplasmic RNAIBA 01/2024 - 03/2023
2	Exonucleases (3' 5' Exonuclease)IBA 11/2023 - 07/2011
2	PlatinumIBA 08/2023 - 01/2022
2	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 01/2018
2	6-methyladenineIBA 01/2023 - 01/2022
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2021
2	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2023 - 01/2020
2	Protein Isoforms (Isoforms)IBA 01/2023 - 03/2014
2	Long Noncoding RNAIBA 01/2023 - 12/2014
2	Sirtuin 1IBA 01/2022 - 01/2018
2	SteroidsIBA 01/2022 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2011
2	PaxillinIBA 11/2020 - 09/2020
2	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 09/2019
2	ImmunosorbentsIBA 10/2019 - 05/2011
2	Benzo(a)pyreneIBA 10/2018 - 05/2010
2	Cyclin D1IBA 06/2018 - 02/2011
2	4,6-dinitro-o-cresol (DNOC)IBA 12/2017 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 12/2015
2	NADPH Oxidase 1IBA 12/2017 - 04/2013
2	Oxidoreductases (Dehydrogenase)IBA 12/2017 - 04/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2017 - 05/2011
2	CateninsIBA 04/2017 - 08/2015
2	Tyrosine Kinase InhibitorsIBA 12/2015 - 06/2014
2	ParaffinIBA 05/2015 - 09/2010
2	Formaldehyde (Formol)FDA Link 05/2015 - 09/2010
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 02/2024
1	Interferon Type IIBA 02/2024
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2024
1	Imatinib Mesylate (Gleevec)FDA Link 01/2024
1	sodium thiosulfate FDA Link 12/2023

Therapy/Procedure

21	Therapeutics 02/2024 - 12/2006
3	Hyperthermic Intraperitoneal Chemotherapy 01/2024 - 01/2022
3	Immunotherapy 11/2023 - 01/2023
3	Drug Therapy (Chemotherapy) 10/2021 - 03/2012
2	Neoadjuvant Therapy 01/2019 - 03/2012
1	Cytoreduction Surgical Procedures 12/2023